- Home
- LPG vs CRMD Comparison
LPG vs CRMD Comparison
Compare LPG & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPG | CRMD |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 958.1M |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | LPG | CRMD |
|---|---|---|
| Price | $27.99 | $11.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $35.00 | $17.43 |
| AVG Volume (30 Days) | 488.1K | ★ 2.9M |
| Earning Date | 01-30-2026 | 11-12-2025 |
| Dividend Yield | ★ 12.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.23 | ★ 2.25 |
| Revenue | ★ $359,008,462.00 | $214,303,672.00 |
| Revenue This Year | $26.79 | $627.89 |
| Revenue Next Year | N/A | $40.95 |
| P/E Ratio | $11.94 | ★ $5.00 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $16.66 | $5.60 |
| 52 Week High | $32.79 | $17.43 |
Technical Indicators
Market Signals| Indicator | LPG | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 73.04 | 45.73 |
| Support Level | $23.86 | $11.62 |
| Resistance Level | $24.45 | $12.29 |
| Average True Range (ATR) | 0.71 | 0.56 |
| MACD | 0.40 | -0.12 |
| Stochastic Oscillator | 95.58 | 12.98 |
Price Performance
Historical ComparisonAbout LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.